Latest News
Understand why the TFSA is essential for your investment strategy, offering tax-free growth and flexible contributions.
Via The Motley Fool · September 23, 2026
CN’s shares have dipped, but the railway’s operating momentum and outlook have improved.
Via The Motley Fool · September 23, 2026
Investors pour over income statements and cash flow trends — but the person deciding what happens to those numbers next matters more, and it's the thing almost nobody knows how to evaluate.
Via The Motley Fool · September 23, 2026
The quantum computing pioneer achieved a major milestone.
Via The Motley Fool · September 23, 2026
These two Canadian stocks would be excellent buys in this persistent inflationary environment.
Via The Motley Fool · September 23, 2026
These features often fly under the radar -- partially because they can be complex, and partially because many plans don’t offer them.
Via The Motley Fool · September 23, 2026
One offers dividend growth, while the other delivers monthly income.
Via The Motley Fool · September 23, 2026
The latest $1 trillion chipmaker now costs about 40 times its expected 2027 earnings. Its bigger, faster-growing competitor costs about 15 times its own.
Via The Motley Fool · September 23, 2026
Putting $7,000 into a TFSA won’t change your life today, but a high-yield monthly payer can start a compounding snowball.
Via The Motley Fool · September 23, 2026
The digital platform provider for the field service industry reported a notable insider sale as its stock plunged 52% over the past year.
Via The Motley Fool · September 23, 2026
Everpure (NYSE:P) outlined a strategy centered on expanding its enterprise storage business while pursuing new opportunities in AI infrastructure, data software and hyperscale deployments, with executives projecting accelerated growth and higher profitability through fiscal 2028.
At the company’s i
Via MarketBeat · September 23, 2026
A 6%+ monthly dividend sounds great, but it only matters if the payout can survive the next oil cycle.
Via The Motley Fool · September 23, 2026
Can Boeing turn its aerospace strengths into a durable recovery? Motley Fool analysts weigh its leadership, debt, and execution risks as they debate the stock's long-term potential.
Via The Motley Fool · September 23, 2026
Stitch Fix (NASDAQ:SFIX) reported fiscal 2026 revenue growth and improved profitability, while executives said a more challenging consumer environment, higher client acquisition costs and temporary first-quarter issues are expected to weigh on fiscal 2027 results.
For fiscal 2026, revenue rose 6.4%
Via MarketBeat · September 23, 2026
Qualcomm (NASDAQ:QCOM) used the second day of its Snapdragon Summit to outline its vision for “personal AI,” highlighting new on-device AI software, wearable reference designs, audio platforms and partnerships intended to support agentic experiences across phones, PCs, cars, glasses and other connec
Via MarketBeat · September 23, 2026
NeoVolta (NASDAQ:NEOV) said fiscal 2026 marked a strategic shift from a primarily residential battery-storage provider toward a broader energy-storage platform spanning residential, commercial and industrial, and utility-scale markets, though the company reported a sharp fourth-quarter revenue decli
Via MarketBeat · September 23, 2026
CPP and OAS can cover a meaningful base, and a diversified dividend portfolio can help fill the gap without forced selling.
Via The Motley Fool · September 23, 2026
McDonald's announced a bold new turnaround plan, but investors don't like the price tag.
Via The Motley Fool · September 23, 2026
One platform is generating record cash flow and closing thousands of AI deals across the enterprise. The other just reached consistent profitability after years of losses and is still earning back investor confidence.
Via The Motley Fool · September 23, 2026
The veteran food company topped analyst estimates in its first quarter of fiscal 2027.
Via The Motley Fool · September 23, 2026
There's been plenty of bad news to digest for Lucid investors, but its recent partnership with Bolt in Europe is at least positive -- even if mostly hype for now.
Via The Motley Fool · September 23, 2026
The economy may be sputtering, but the luxury travel niche is not.
Via The Motley Fool · September 23, 2026
The chipmaker set this deadline itself. Its chief financial officer is starting to sound like a company that already knows the answer.
Via The Motley Fool · September 23, 2026
Why Leon's Furniture's cash-rich balance sheet and free cash flow may appeal to value investors.
Via The Motley Fool · September 23, 2026
GSK (NYSE:GSK) is advancing a respiratory and immunology pipeline centered on longer-acting biologics, more targeted patient selection and combination approaches, according to Kaivan Khavandi, the company’s senior vice president and global head of Translational and Development Sciences.
Speaking at
Via MarketBeat · September 23, 2026